By Quest Diagnostics
3.7
66 ratings
The podcast currently has 18 episodes available.
In this episode of Diagnostics Dialogues - Innovation & Insight, Dr. Pat Alagia is joined by two brilliant Quest colleagues, Senior Surgical Pathologist and Cytopathologist Dr. Elena Enbom, and Managing & Medical Director of Anatomic Pathology & Director of The Center of Excellence for Digital & AI-Empowered Pathology, Dr. Piotr Borkowski. Together they bring you an in-depth look into the future of pathology, and share how the exciting and evolving world of AI can enhance pathologists’ important task of diagnosing patients. During the chat, the doctors explore how the use of AI can help free up pathologists to tackle the most critical work for their patients. Plus, the guests illustrate the key time-saving benefits of AI usage in pathology that can improve patient outcomes by helping assess massive quantities of data in a much shorter amount of time than ever before. So press play and get ready to learn all about the amazing ways that Artificial Intelligence can aid pathologists, thus providing huge benefits to both patients and healthcare systems.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
In this installment of our two-part series on the fundamental pillars of laboratory-based diagnostic patient care, Dr. Pat Alagia is joined by two of the top minds in laboratory medicine and anatomic pathology, Dr. Hope Karnes and Dr. Darren Wheeler.
Offering a deep dive into the evolving world of pathology, they bring to light how the work of pathologists extends far beyond the microscope, spotlighting their integral roles in diagnosing patients and managing clinical laboratories. Throughout the conversation, the doctors shed light on the transformation of the patient experience in cancer treatment, detailing the shift from invasive procedures to targeted therapies made possible by smaller tissue samples and precise classification. Plus, Dr. Karnes and Dr. Wheeler illuminate the increasing significance of molecular studies in cancer diagnostics, painting a picture of a future where treatment is customized, producing better outcomes with fewer side effects. The episode is also peppered with insights on the exciting advancements of AI, digital pathology, and big data in crafting a more meticulous and hopeful approach to cancer care. So press play and get ready to learn all about the incredible value that pathologists and laboratorians provide patients, physicians, and caregivers across healthcare systems.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! For this episode, Dr Pat Alagia is joined by Vice President & General Manager of Women’s and Reproductive Health at Quest Diagnostics, Kathleen Valentine, and Quest's Director and Medical Science Liaison for Women’s Health, Dr. Karen Racicot. Together, the group discusses the importance of genetic carrier and prenatal screening, as well as Quest's commitment to health equity and treating women throughout every stage of their lives. This episode is one of our favorites, so get ready for another thoughtful conversation with the brightest minds in healthcare and join us for Diagnostics Dialogues - Innovation & Insight, from Quest Diagnostics.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! In this episode, Dr Pat Alagia is joined by Mike Lukas, Vice President and General Manager of Health Systems at Quest Diagnostics. Mike has led considerable growth at Quest, leading to impressive contributions to health systems and academic medical centers. Mike joins Dr Alagia to talk about the importance of trust in the partnership between a health system and the laboratory. Later, the pair dive into the current challenges in the healthcare space and how his team delivers collaborative solutions, and Mike explains his commitment to investing in becoming an even better laboratory partner and continuing to grow to address emerging needs. This episode of Diagnostics Dialogues - Innovation & Insight from Quest Diagnostics is not to be missed, so get ready for another in-depth, thought-provoking conversation with the brightest minds in healthcare!
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! In this episode, Dr Pat Alagia is joined by Dr Steve Goldberg, Vice President, Chief Health Officer, Employee and Population Health at Quest Diagnostics. Dr Goldberg is a brilliant physician who partners with employers, health plans, hospitals, health systems, and provider organizations to inform diagnosis and treatment to contribute to a healthier world. He sits down with Dr Alagia to discuss how diagnostics insights can help improve the health and wellbeing of both individuals and communities. Plus, the duo digs deep into the many benefits of employer health and wellness programs, explaining how they can help organizations empower better employee health and reduce spending. This is one episode of Diagnostics Dialogues - Innovation & Insight from Quest Diagnostics that you don’t want to miss, so sit back, hit play, and get ready for another in-depth, thought-provoking conversation with the brightest minds in healthcare!
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Welcome back to another episode of Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders. Today, host Dr Pat Alagia is speaking with Dr Darren Wheeler, Vice President of Pathology and Medical Services at Quest Diagnostics. Dr Wheeler joins us to discuss and examine how Quest, as the leader in advanced diagnostics, is actively participating in the creation and use of new technologies that further the mission to make precision medicine clinically accessible, actionable, and economical. Not to mention he touches on the implementation progress of digital pathology and artificial intelligence in various fields of medicine. So press play and join us for this insightful episode of Diagnostics Dialogues - Innovation & Insight from Quest Diagnostics.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Welcome to Season 2 of Diagnostic Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! Today, host Dr Pat Alagia is joined by Dr Hema Kapoor and Dr Robert Jones to discuss disease surveillance! The trio talk about why COVID took the world by surprise and what they have learned about preventative measures and testing in order to better prepare for future pandemics like Monkeypox. Plus, the doctors speak about surveillance as the key to identifying novel viruses and address privacy concerns in regards to data collection. Hit play and enjoy this episode of Diagnostic Dialogues - Innovation & Insight from Quest Diagnostics.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
Tune in to Season 2 of Diagnostic Dialogues - Innovation & Insight and join entrepreneurial, innovative, and forward-thinking physician, Dr Pat Alagia as he speaks with top researchers, doctors, and thought leaders about the hottest topics in healthcare. From the latest in cutting-edge research to what’s coming next in the world of diagnostic medicine, this is a must hear podcast for those wanting the inside track on the engines that power the healthcare ecosystem.
Follow Us
Presented by Quest Diagnostics
www.questdiagnostics.com
The number of Americans living with Alzheimer's Disease (AD) continues to grow at an exponential rate. Currently, more than 6 million Americans have AD, and that number is expected to double by 2050. But recent research findings are beginning to show the important role diagnostics may play in the next era of AD. New diagnostic innovations could unleash a future of effective therapies, treatments, and improved outcomes for patients who suffer from this disease.
In this episode, host Dr Pat Alagia, Senior Medical Director for Women’s and Reproductive Health at Quest Diagnostics, welcomes Dr Michael K. Racke to discuss:
About our guests
Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. He is a leader in the field of neurology and neuroimmunology with special expertise in multiple sclerosis.
After receiving his Doctor of Medicine from the University of Medicine and Dentistry of New Jersey, Dr Racke completed a medical internship and neurology residency at Emory University School of Medicine, followed by a neuroimmunology fellowship at the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH).
Dr Racke’s research focuses on developing novel tests for neurologic disorders, including monitoring therapeutic responses in diseases such as multiple sclerosis. He has authored more than 200 peer-reviewed papers, book chapters, and reviews on the pathogenesis of neuroimmunology diseases. He has over 3 decades of leadership experience in academia and clinical practice and continues to serve on several national professional society committees.
Dr Racke is board certified by the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology and American Association of Immunologists.
------------------------------
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
More information is available at www.QuestDiagnostics.com
In today’s healthcare environment, laboratory leaders are required to provide the highest quality services to support improved patient outcomes. To succeed, they must implement scalable medical, analytical, and operational strategies, all while driving and balancing fiscal excellence and responsibility.
In this episode, host Dr Pat Alagia, Senior Medical Director for Women’s and Reproductive Health at Quest Diagnostics welcomes Dr Patrick Mason and Tammy Germini to discuss:
About our guests
Patrick Mason, MD, PhD, is Regional Medical Director of the Quest Diagnostics Nichols Institute in Chantilly, VA.
Dr Mason received his undergraduate, a PhD in Biochemistry, and Doctor of Medicine training at Virginia Commonwealth University. He completed his pediatric residency and endocrinology fellowship at Emory University. Dr Mason remained on the Emory faculty for several years until moving to Inova Fairfax Hospital for Children in 2001. While at Inova, he held a variety of positions, including staff pediatric endocrinologist and director of pediatric research. He held positions as assistant clinical professor of pediatrics at both Virginia Commonwealth University and the University of Virginia and was appointed as special volunteer faculty at Development Endocrinology Branch, National Institute of Child Health and Development, and National Institutes of Health (NIH).
Dr Mason joined the Quest Diagnostics Nichols Institute in March 2011 and served as the Medical Director of Endocrinology until April 2015 when he became the Medical Director of the Chantilly laboratory.
Tammy Germini, MBA, MT(ASCP), is the Executive Director of Operations for Health Systems at Quest Diagnostics where she oversees the implementation of key strategies aimed to balance operational excellence and financial responsibility.
After earning a Bachelor of Science in Medical Technology from the University of North Carolina, Greensboro, she attended the Moses H. Cone School of Medical Technology and was certified by the Board of Certification of the American Society for Clinical Pathology in July 1995. She received her Master’s in Business Administration from the University of Scranton in August 2017.
Tammy worked for Spectrum Laboratory Network for 15 years as a medical technologist, supervisor, and remote site manager. She then progressed in her career to Geisinger Medical Center where she led the laboratory for 11 years as the Director of Laboratory Excellence and Operations Director for Clinical Pathology. Her tenure at Geisinger included oversight of the operations and financial performance for 6 nonprofit hospital laboratories, including the core laboratory for a large health system producing more than 10 million tests per year. Some of her key achievements include participation in the design and transition to a new 115,000 square foot state-of-the-art laboratory building in 2015, successful mergers/acquisitions of 5 hospital laboratories, and successful consolidation of operations into a core lab model.
------------------------------
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management. Quest Diagnostics annually serves 1 in 3 adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
More information is available at www.QuestDiagnostics.com
The podcast currently has 18 episodes available.